Amicus Therapeutics (FOLD), Glaxo (GSK) Report Study 011 Did Not Achieve Primary Endpoint
Go back to Amicus Therapeutics (FOLD), Glaxo (GSK) Report Study 011 Did Not Achieve Primary Endpoint| Amicus Therapeutics, Inc. (NASDAQ: FOLD) | Delayed: 14.49 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.49 | 52 Week High | $11.78 | |||
| Open | $14.49 | 52 Week Low | $4.98 | |||
| Day High | $14.49 | P/E | N/A | |||
| Day Low | $14.49 | EPS | $-1.15 | |||
| Volume | 1,197,383 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 51.69 -0.38 (0.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $52.07 | 52 Week High | $45.58 | |||
| Open | $51.94 | 52 Week Low | $37.82 | |||
| Day High | $51.98 | P/E | N/A | |||
| Day Low | $51.38 | EPS | $0.00 | |||
| Volume | 3,982,165 | |||||
